[Use of heptaminol hydrochloride as adjuvant in therapy o alcoholics]. 1959

LUTZ-JAEHN, and SCHAETZEL

UI MeSH Term Description Entries
D006535 Heptaminol An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol's therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism. Cardiomax,Heptaminol Hydrochloride
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000277 Adjuvants, Pharmaceutic Agents that aid or increase the action of the principle drug (DRUG SYNERGISM) or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug (PHARMACOKINETICS) in such a way as to enhance its effects. Adjuvant, Pharmaceutic,Adjuvant, Pharmaceutical,Adjuvants, Pharmaceutical,Pharmaceutic Adjuvant,Pharmaceutic Adjuvants,Pharmaceutical Adjuvant,Pharmaceutical Adjuvants
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D000605 Amino Alcohols Compounds possessing both a hydroxyl (-OH) and an amino group (-NH2). Alcohols, Amino
D057229 Alcoholics Persons who have a history of physical or psychological dependence on ETHANOL. Skid Row Alcoholics,Alcoholic,Alcoholic, Skid Row,Alcoholics, Skid Row,Skid Row Alcoholic

Related Publications

LUTZ-JAEHN, and SCHAETZEL
April 1967, Die Medizinische Welt,
LUTZ-JAEHN, and SCHAETZEL
July 1990, Canadian journal of physiology and pharmacology,
LUTZ-JAEHN, and SCHAETZEL
August 1967, Hippokrates,
LUTZ-JAEHN, and SCHAETZEL
January 1961, Therapie,
LUTZ-JAEHN, and SCHAETZEL
January 2012, American journal of therapeutics,
LUTZ-JAEHN, and SCHAETZEL
January 1962, Comptes rendus des seances de la Societe de biologie et de ses filiales,
LUTZ-JAEHN, and SCHAETZEL
January 1972, Cahiers d'anesthesiologie,
LUTZ-JAEHN, and SCHAETZEL
May 1955, Comptes rendus des seances de la Societe de biologie et de ses filiales,
Copied contents to your clipboard!